High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia — an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia — an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Published:2016-03-29 Issue:19 Volume:7 Page:27255-27266
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Czerw Tomasz¹,Labopin Myriam²³⁴,Schmid Christoph⁵,Cornelissen Jan J.⁶,Chevallier Patrice⁷,Blaise Didier⁸,Kuball Jürgen⁹,Vigouroux Stephane¹⁰,Garban Frédéric¹¹,Lioure Bruno¹²,Fegueux Nathalie¹³,Clement Laurence¹⁴,Sandstedt Anna¹⁵,Maertens Johan¹⁶,Guillerm Gaëlle¹⁷,Bordessoule Dominique¹⁸,Mohty Mohamad²³⁴,Nagler Arnon¹⁹²

Affiliation:

1. Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Gliwice, Poland

2. Clinical Hematology and Cellular Therapy Department, The Acute Leukemia Working Party of the EBMT office, Hopital Saint-Antoine APHP Paris, France

3. INSERM UMRs 938, Paris, France

4. Université Pierre et Marie Curie (UPMC, Paris VI), Paris, France

5. Klinikum Augsburg, University of Munich, Munich, Germany

6. Department of Hematology, Erasmus University medical center Cancer Institute, Rotterdam, The Netherlands

7. CHU Nantes, Dept. D'Hematologie, Nantes, France

8. Unité de transplantation et de thérapie cellulaire, Institut Paoli Calmettes, Marseille, France

9. University Medical Centre, Dept. of Haematology, Utrecht, The Netherlands

10. CHU Bordeaux, Hôpital Haut-leveque, Pessac, France

11. Hopital A. Michallon, Hématologie Clinique, Pole Cancérologie, Grenoble, France

12. Nouvel Hopital Civil, Strasbourg, France

13. CHU Lapeyronie, Département d'Hématologie Clinique, Montpellier, France

14. Hôpital de Brabois, Centre Hospitalier Universitaire (CHU) de Nancy, Vandoeuvres les Nancy, France

15. University Hospital, Dept. of Hematology, Linköping, Sweden

16. University Hospital Gasthuisberg, Dept. of Hematology, Leuven, Belgium

17. CHU Morvan, Brest, France

18. CHRU Limoges, Service d'Hématologie Clinique, Limoges, France

19. Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis;Bone Marrow Transplantation;2024-07-27

2. Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia;Leukemia & Lymphoma;2024-07-07

3. High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality;Transfusion;2024-05

4. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center study with a Japanese cohort;Blood Cells, Molecules, and Diseases;2024-03

5. Clinical and Biological Concepts for Mastering Immune Reconstitution After Hematopoietic Cell Transplantation: Toward Practical Guidelines and Greater Harmonization;The EBMT Handbook;2024